Humacyte, Inc. Increase (Decrease) in Inventories
Humacyte, Inc. (HUMA) reported Increase (Decrease) in Inventories of -$4.31 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-12.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInInventories · last filed 2026-08-12
- Humacyte, Inc. increase (decrease) in inventories for the quarter ending 2026-06-30 was -$2.27M, a 176.87% decline year-over-year.
- Humacyte, Inc. increase (decrease) in inventories for the quarter ending 2026-03-31 was -$2.04M, a 125.47% decline year-over-year.
- Humacyte, Inc. increase (decrease) in inventories for the quarter ending 2025-12-31 was $3.56M.
- Humacyte, Inc. increase (decrease) in inventories for the quarter ending 2025-09-30 was $7.30M.
- Humacyte, Inc. increase (decrease) in inventories for fiscal 2025 was $21.83M.
- Humacyte, Inc. increase (decrease) in inventories for fiscal 2024 was $0.00.
| Period end | Increase (Decrease) in Inventories 3 month | Increase (Decrease) in Inventories 6 month | Increase (Decrease) in Inventories 9 month | Increase (Decrease) in Inventories 12 month |
|---|---|---|---|---|
| 2026-06-30 | -$2.27M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-12 | -$4.31M 10-Q · filed 2026-08-12 | -$752.00K derived: sum of 3 quarters · filed 2026-08-12 | $6.55M derived: sum of 4 quarters · filed 2026-08-12 |
| 2026-03-31 | -$2.04M 10-Q · filed 2026-05-13 | $1.51M derived: sum of 2 quarters · filed 2026-05-13 | $8.82M derived: sum of 3 quarters · filed 2026-05-13 | $11.76M derived: sum of 4 quarters · filed 2026-08-12 |
| 2025-12-31 | $3.56M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-27 | $10.86M derived: sum of 2 quarters · filed 2026-03-27 | $13.81M derived: sum of 3 quarters · filed 2026-08-12 | $21.83M 10-K · filed 2026-03-27 |
| 2025-09-30 | $7.30M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-12 | $10.25M derived: sum of 2 quarters · filed 2026-08-12 | $18.27M 10-Q · filed 2025-11-12 | $18.27M derived: sum of 4 quarters · filed 2026-08-12 |
| 2025-06-30 | $2.95M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-12 | $10.97M 10-Q · filed 2026-08-12 | $10.97M derived: sum of 3 quarters · filed 2026-08-12 | $10.97M derived: sum of 4 quarters · filed 2026-08-12 |
| 2025-03-31 | $8.02M 10-Q · filed 2026-05-13 | $8.02M derived: sum of 2 quarters · filed 2026-05-13 | $8.02M derived: sum of 3 quarters · filed 2026-05-13 | $8.02M derived: sum of 4 quarters · filed 2026-05-13 |
| 2024-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-27 | $0.00 derived: sum of 2 quarters · filed 2026-03-27 | $0.00 derived: sum of 3 quarters · filed 2026-03-27 | $0.00 10-K · filed 2026-03-27 |
| 2024-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-12 | $0.00 derived: sum of 2 quarters · filed 2025-11-12 | $0.00 10-Q · filed 2025-11-12 | |
| 2024-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-11 | $0.00 10-Q · filed 2025-08-11 | ||
| 2024-03-31 | $0.00 10-Q · filed 2025-05-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Outlook Therapeutics, Inc. (OTLK) | United States | $0.162B | -4.90 |
| Acumen Pharmaceuticals, Inc. (ABOS) | United States | $0.162B | -1.83 |
| Tenaya Therapeutics, Inc. (TNYA) | United States | $0.140B | -1.60 |
| Voyager Therapeutics, Inc. (VYGR) | United States | $0.173B | -1.99 |
| PRECISION BIOSCIENCES INC (DTIL) | United States | $0.175B | -3.95 |
| Caribou Biosciences, Inc. (CRBU) | United States | $0.134B | -1.79 |
| Armata Pharmaceuticals, Inc. (ARMP) | United States | $0.132B | |
| Neumora Therapeutics, Inc. (NMRA) | United States | $0.132B | -1.48 |
| enGene Therapeutics Inc. (ENGN) | $0.129B | -0.92 | |
| Coherus Oncology, Inc. (CHRS) | United States | $0.182B | -1.63 |